IP Verse

Safe Desmopressin Administration - EP3278809B1

PatentPatent Analysis

EP3278809

ALLERGAN
Application Number
EP17168865A
Filing Date
Jun 15, 2010
Status
Revoked
May 20, 2022
Grant Date
Nov 20, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2442821B2
EP3509559B8
EP2877138B1

Bibliography

The patent EP3278809B1 was granted to Allergan on Nov 20, 2019 following the initial filing on Jun 15, 2010 under the application number EP17168865A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

FERRINGAug 20, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents